GO:0008142 oxysterol binding: Mechanism, Genes and Research

Oxysterol binding (GO:0008142) is a molecular function that mediates the interaction of proteins with oxysterols, which are oxidized derivatives of cholesterol. This function is primarily executed by the oxysterol-binding protein (OSBP) family and OSBP-related proteins (ORPs), a conserved group of lipid transfer proteins found from yeast to humans. These proteins are characterized by a pleckstrin homology (PH) domain that targets them to specific membranes and an OSBP-related domain (ORD) that binds oxysterols and facilitates lipid exchange. The biological significance of oxysterol binding extends far beyond simple lipid sequestration; it is central to cholesterol and phosphatidylinositol 4-phosphate (PI(4)P) homeostasis, membrane trafficking, and signal transduction [1,5]. Researchers are increasingly interested in oxysterol binding because of its broad impact on human health and disease. OSBP and ORPs have been implicated in cancer progression, where they contribute to aberrant lipid metabolism and drug resistance. In the immune system, oxysterol binding proteins regulate macrophage responses to 25-hydroxycholesterol, influencing lysosomal AMP kinase activation and metabolic reprogramming. Oxysterols themselves act as signaling molecules that restrain cholesterol synthesis and prevent AIM2 inflammasome activation, a process that depends on oxysterol binding proteins. Furthermore, ORP6 has been shown to regulate lipid metabolism and amyloid-beta production in the brain, linking oxysterol binding to Alzheimer's disease pathology. Given the growing recognition of oxysterol binding in health and disease, this article provides a comprehensive overview of the GO:0008142 function, its molecular mechanism, key genes, and the experimental models used to study it. We integrate authoritative QuickGO data with verified PubMed literature to support researchers in designing robust experiments and interpreting their findings [1-8].

According to the Gene Ontology, oxysterol binding (GO:0008142) is the molecular function of selectively interacting with an oxysterol, which is an oxidized form of cholesterol. This binding event is non-covalent and reversible, and it is typically mediated by a conserved ligand-binding pocket within proteins such as OSBP and ORPs. The function does not imply catalysis but rather the recognition and transport of oxysterols or the regulation of protein activity upon oxysterol binding.

Oxysterol binding is important because it sits at the crossroads of cholesterol metabolism, lipid trafficking, and cell signaling. Proteins that bind oxysterols, such as OSBP and ORPs, are essential for maintaining the distinct lipid compositions of cellular organelles and for transmitting signals that control cell growth, immune responses, and neuronal function [1,5]. Dysregulation of oxysterol binding has been directly linked to cancer, where it promotes tumor cell survival and proliferation, and to neurodegenerative conditions like Alzheimer's disease through the regulation of amyloid-beta production. Moreover, oxysterol binding proteins are critical for immune cell function, including the metabolic reprogramming of macrophages and the prevention of inflammasome activation [3,7]. Understanding this function therefore offers therapeutic opportunities for a wide range of diseases.

The following genes encode proteins that directly mediate oxysterol binding or are closely associated with this function.

Oxysterol binding is regulated at multiple levels. The availability of oxysterol ligands is controlled by enzymes such as CH25H and CYP46A1, which synthesize 25-hydroxycholesterol and 24(S)-hydroxycholesterol, respectively [3,7]. The subcellular localization of OSBP/ORPs is dynamically regulated by phosphoinositide signaling; for example, PI(4)P levels at the Golgi determine OSBP recruitment and activity. Additionally, phosphorylation and other post-translational modifications of OSBP/ORPs can modulate their binding affinity and function. In immune cells, 25-hydroxycholesterol binding to OSBP/ORPs activates AMP kinase and reprograms metabolism, illustrating ligand-dependent regulation.

Oxysterol binding proteins are frequently dysregulated in cancer, where they support tumor cell proliferation and survival by altering lipid metabolism and signaling. OSBP and ORPs contribute to the rewiring of cholesterol and PI(4)P homeostasis that is characteristic of many cancers, making them potential therapeutic targets [1,6].

In the brain, oxysterol binding proteins such as ORP6 regulate lipid metabolism and amyloid-beta production, directly linking oxysterol binding to Alzheimer's disease pathogenesis. The enzyme CYP46A1, which produces the oxysterol 24(S)-hydroxycholesterol, is also implicated in neurodegeneration, further highlighting the importance of this function.

Oxysterol binding mediates the immunomodulatory effects of 25-hydroxycholesterol, including the education of immunosuppressive macrophages and the restraint of AIM2 inflammasome activation [3,7]. Dysregulation of this function can lead to excessive inflammation or impaired immune responses, contributing to autoimmune and inflammatory diseases [3,7].

Given the central role of oxysterol binding in cholesterol and lipid homeostasis, its dysfunction is linked to metabolic disorders such as atherosclerosis, obesity, and non-alcoholic fatty liver disease. OSBP/ORPs regulate lipid droplet formation and lipoprotein secretion, processes that are critical for metabolic health.

Direct measurement of oxysterol binding can be performed using radiolabeled oxysterols or fluorescent lipid probes in equilibrium binding assays. These methods determine binding affinity and specificity for different oxysterol species.

Mass spectrometry-based lipidomics allows comprehensive profiling of oxysterols and other lipids in cells and tissues, revealing changes in oxysterol levels upon genetic or pharmacological perturbation [1,3].

Fluorescently tagged OSBP/ORPs and lipid biosensors can be used to visualize membrane contact sites, lipid transfer, and protein dynamics in real time [4,5]. This approach is essential for understanding the spatiotemporal regulation of oxysterol binding.

Genome-wide CRISPR knockout or activation screens can identify genes that modulate oxysterol binding and downstream phenotypes, such as cholesterol homeostasis or immune cell function [1,6].

Researchers studying oxysterol binding-related genes often need to determine whether a candidate gene is causally involved in lipid transport, immune regulation, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process, from gene knockout to precise point mutations and library screening.

Oxysterol binding (GO:0008142) is a fundamental molecular function that governs lipid transport, cell signaling, and immune regulation. The OSBP/ORP family of proteins mediates this function, and their dysfunction is implicated in a wide range of human diseases, including cancer, Alzheimer's disease, and metabolic disorders [1,2,6]. Continued research using advanced CRISPR models and lipidomics will further elucidate the mechanistic details and therapeutic potential of oxysterol binding [3,5]. EDITGENE provides comprehensive CRISPR services to support researchers in exploring oxysterol binding-related genes, from knockout to precise point mutations and library screening. By leveraging these tools, the scientific community can accelerate discoveries that may lead to novel treatments for diseases linked to oxysterol dysregulation.